Effects of prophylactic tranexamic acid on bleeding during transbronchial lung biopsy: a double-blind, randomized controlled trial
Authors:
- Marzieh RostamiMRMarzieh Rostami
- Ali DabbaghADAli Dabbagh
- Alireza JolousJamshidiAJAlireza JolousJamshidi
- Alireza ShakeriASAlireza Shakeri
- Kamal FaniKFKamal Fani
- Marzie ShahrabiMSMarzie Shahrabi
- Hamidreza SamadpourHSHamidreza Samadpour
- Seyed Mohammad Seyed-AlshohadaeiSSSeyed Mohammad Seyed-Alshohadaei
- Maede KarimianMKMaede Karimian
Open Access
- 15 July 2026
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (8) , 5061-5066
Abstract
Background: This randomized controlled trial evaluated the efficacy of tranexamic acid in preventing bleeding in patients undergoing transbronchial lung biopsy. Materials and methods: This study was a double-blind, parallel-group, randomized controlled trial. Adult patients referred for flexible bronchoscopy with a planned transbronchial lung biopsy during 2024 were included in the current study. Participants in the intervention group received 10 mg/kg of intravenous tranexamic acid in normal saline, administered 20 minutes prior to the procedure. Those in the placebo group received an equal volume of normal saline. We assessed the need for bleeding control interventions, such as epinephrine or ice saline use, the incidence of tachycardia or hypotension, uncontrolled bleeding, and procedure length. We also measured the hemoglobin levels before and after the procedure. Results: In total, 60 patients – 32 (53.3%) in the tranexamic acid group and 28 (46.7%) in the control group – were enrolled in the study. The percentage of females (53.6% vs. 28.1%) and the mean age of participants (66.5 vs. 42.9 years) were significantly higher in the control group compared to the tranexamic acid group ( P < 0.05). After adjusting for age and gender, epinephrine use (18.8% vs. 92.9%) and the procedure length (median of 8 vs. 13 minutes) were lower in the tranexamic acid group compared to the control group ( P < 0.05). Additionally, tranexamic acid had a statistically significant effect on post-operative hemoglobin levels (F = 14.08, P < 0.001, partial η 2 = 0.207). Conclusions: Tranexamic acid can be effective in preventing bleeding in individuals undergoing transbronchial lung biopsy and in enhancing procedural speed.Keywords
This publication has 23 references indexed in Scilit:
- CONSORT 2025 statement: updated guideline for reporting randomised trialsThe Lancet, 2025
- Prophylactic use of tranexamic acid for prevention of bleeding during transbronchial lung biopsies - A randomized, double-blind, placebo-controlled trialRespiratory Medicine, 2020
- Standardized Definitions of Bleeding After Transbronchial Lung BiopsyChest, 2020
- Utility of Transbronchial vs Surgical Lung Biopsy in the Diagnosis of Suspected Fibrotic Interstitial Lung DiseaseChest, 2017
- Transbronchial lung biopsy: the pathologist's point of viewThe Clinical Respiratory Journal, 2014
- Population-based estimates of transbronchial lung biopsy utilization and complicationsRespiratory Medicine, 2012
- Incidence of Intraoperative Hypotension as a Function of the Chosen DefinitionAnesthesiology, 2007
- Evaluation of aprotinin and tranexamic acid in different and models of fibrinolysis, coagulation and thrombus formationJournal of Thrombosis and Haemostasis, 2007
- Risk factors and management of bleeding associated with transbronchial lung biopsy in lung transplant recipientsThe Journal of Heart and Lung Transplantation, 2003
- The Role of Open Lung Biopsy in the Management and Outcome of Patients With Diffuse Lung DiseaseThe Annals of Thoracic Surgery, 1998